Fabry disease: preclinical studies demonstrate the effectiveness of alpha-galactosidase A replacement in enzyme-deficient mice.

Source:http://linkedlifedata.com/resource/pubmed/id/11115376

Download in:

View as

General Info

PMID
11115376